In addition to cardiovascular monitoring, BioTelemetry Research, formerly Cardiocore, has now expanded to include full-service imaging capabilities for clinical trials. Supporting all major areas of drug and device research imaging, we offer a complete suite of services, using an advanced cloud-based platform that is Part 11 FDA-compliant and always accessible. Our team includes board-certified radiologists, sub-specialty experts, thought leaders, and highly trained technicians, who are dedicated to help design and implement the optimal protocol to acquire, evaluate, and transfer accurate, high-quality data through an efficient, cost-effective, and state-of-the-art global infrastructure.

Contact us for information about clinical trial imaging support, including for any of the following therapeutic areas:

Cardiovascular Imaging

​BioTelemetry Research, formerly Cardiocore, has vast experience in echocardiography (ECHO) and maintains a state-of-the-art ECHO processing infrastructure. Experienced physicians perform all ECHO analyses, including quantification of cardiac chamber size, ventricular mass, cardiac function, volume, and wall thickness. Display modes include 2-D, M-Mode, Doppler, and Tissue Doppler. These procedures are based on the American Society for Echocardiography guidelines, which are widely applied to clinical research and clinical practice. Our comprehensive list of modalities in cardiovascular imaging include:
  • Angiography
  • Computed Tomography (CT)
  • Echocardiography (ECHO)
  • Magnetic Resonance Imaging (MRI)
  • Multi-Gated Acquisition Scan (MUGA)
  • Single-Photon Emission Computed Tomography (SPECT)
  • Positron Emission Tomography (PET)
  • Ultrasound

Oncology Imaging

The pipeline of potential cancer treatments continues to expand, necessitating an increasing number of clinical trials utilizing imaging. BioTelemetry Research, formerly Cardiocore, provides support in the following Oncology imaging modalities:
  • Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
  • Positron Emission Tomography (PET)
  • Bone Scan
  • X-ray
  • Photography
Imaging services are available across Oncology response criteria including but not limited to:
  • RECIST 1.0/1.1
  • WHO
  • EASL
  • mRECIST for HCC
  • PCWG2
  • irRC/irRECIST
  • RANO/McDonald
  • Cheson/Lugano
  • Choi
  • SUV-based PET analysis

Musculoskeletal Imaging

BioTelemetry Research provides support for the following Musculoskeletal imaging modalities:
  • Computed Tomography (CT)
  • Dual Energy X-Ray Absorptiometry (DXA)
  • Magnetic Resonance Imaging (MRI)
  • Ultrasound
  • X-Ray
Imaging services are available across Musculoskeletal imaging indications including but not limited to:
  • DXA (BMD, Body Composition)
  • CT/MRI Body Composition
  • Sharp Scores
  • WORMS
  • Kellgren & Lawrence
  • Joint Space Width
  • Cartilage Thickness/Volume
  • Spinal Device/Fusion Measures

Neurologic Imaging

BioTelemetry Research provides support for the following Neurologic imaging modalities:
  • Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
  • Positron Emission Tomography (PET)
  • Single-Photon Emission Computed Tomography (SPECT)